Clinical Trials

    Showing 1 - 5 of 5 Amyotrophic Lateral Sclerosis (ALS)

    Status: Enrolling

    Investigator: Sheetal Shroff

    Study Coordinator: Aramide Balogun

    Phone: 713.441.6955

    In Amyotrophic Lateral Sclerosis (ALS), the reduction of regulatory T lymphocyte (Treg) numbers and suppressive function correlates with rapid disease progression. We completed a phase 1 study of infusions of expanded autologous Tregs in combination ... Read more >

    Status: Enrolling

    Investigator: Stanley Appel

    Study Coordinator: Aramide Balogun

    Phone: 713.441.6955

    The purpose of this protocol is to develop and maintain a biospecimen bank comprised of blood, urine, CSF collected during diagnostic evaluations, tissue from biopsies and autopsies collected from patients with neurological disease and non-neurolog... Read more >

    Status: Open Not Enrolling

    Investigator: Stanley Appel

    Study Coordinator: Aramide Balogun

    Phone: 713.441.6955

    The purpose of this protocol is to develop and maintain a clinical findings data bank including diagnostic evaluations obtained from medical records sent from prior medical evaluations, diagnostic intake evaluations and follow-up care in the Methodis... Read more >

    Status: Open Not Enrolling

    Investigator: Stanley Appel

    Study Coordinator: Aramide Balogun

    Phone: 713.441.6955

    The purpose of the this study to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progress wi... Read more >

    Status: Enrolling

    Investigator: Sheetal Shroff

    Study Coordinator:

    Phone:

    The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.... Read more >